REGIONAL HETEROGENEITY IN THE PROLIFERATIVE ACTIVITY OF HUMAN GLIOMAS AS MEASURED BY THE KI-67 LABELING INDEX

被引:124
作者
COONS, SW
JOHNSON, PC
机构
[1] Division of Neuropathology, Barrow Neurological Institute of St. Joseph’s Hospital and Medical Center, Phoenix, AZ
关键词
GLIOMAS; HISTOLOGIC GRADING; KI-67; PROLIFERATION; REGIONAL HETEROGENEITY;
D O I
10.1097/00005072-199311000-00008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The effects of regional heterogeneity on the accuracy of histological grading of gliomas are well known, but little has been reported about its implications for other diagnostic modalities. This study investigated the relationships of regional heterogeneity in tumor proliferative activity, measured by Ki-67 labeling indices (LI), and histological grades for 16 regionally sampled glioma resections. There was a strong correlation between histological grades and Ki-67 LI in individual regions (p < 0.001), and both methods demonstrated comparable heterogeneity. Heterogeneity increased with tumor grade, probably as an expression of the increased genetic instability that accompanies tumor progression. Similarly, regions with comparable proliferative activity tended to cluster, paralleling clonal expansion. Thus, both histological grading and Ki-67 LI are subject to heterogeneity-induced sampling errors that limit their diagnostic accuracy, particularly in small biopsies. However, fewer grading errors occurred when using both methods together than when using either method alone, suggesting that the use of multiple techniques may reduce the adverse effects of regional heterogeneity on diagnostic accuracy. Regional heterogeneity appears to be a ubiquitous feature of gliomas: it also has been reported in karyotype, p53 oncogene mutations, and PDGF and EGFR expression. The effects of regional heterogeneity on new methods for studying gliomas need to be considered.
引用
收藏
页码:609 / 618
页数:10
相关论文
共 53 条
  • [1] PROLIFERATING CELL NUCLEAR ANTIGEN EXPRESSION IN CENTRAL-NERVOUS-SYSTEM NEOPLASMS
    ALLEGRANZA, A
    GIRLANDO, S
    ARRIGONI, GL
    VERONESE, S
    MAURI, FA
    GAMBACORTA, M
    POLLO, B
    DALLAPALMA, P
    BARBARESCHI, M
    [J]. VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1991, 419 (05) : 417 - 423
  • [2] BELL C, 1991, CANCER GENET CYTOGEN, V59, P153
  • [3] BENEDIKTSSON G, 1989, ANTICANCER RES, V9, P1483
  • [4] CLONAL COMPOSITION OF GLIOBLASTOMA-MULTIFORME
    BERKMAN, RA
    CLARK, WC
    SAXENA, A
    ROBERTSON, JT
    OLDFIELD, EH
    ALI, IU
    [J]. JOURNAL OF NEUROSURGERY, 1992, 77 (03) : 432 - 437
  • [5] BIOLOGY OF GLIOMAS - POTENTIAL CLINICAL IMPLICATIONS OF GLIOMA CELLULAR HETEROGENEITY
    BIGNER, DD
    [J]. NEUROSURGERY, 1981, 9 (03) : 320 - 326
  • [6] BISHOP M, 1989, AM J PATHOL, V135, P517
  • [7] BURGER PC, 1985, CANCER, V56, P1106, DOI 10.1002/1097-0142(19850901)56:5<1106::AID-CNCR2820560525>3.0.CO
  • [8] 2-2
  • [9] BURGER PC, 1989, CANCER-AM CANCER SOC, V63, P2014, DOI 10.1002/1097-0142(19890515)63:10<2014::AID-CNCR2820631025>3.0.CO
  • [10] 2-L